Programmbereich Infektionen

Mikrobielle Grenzflächenbiologie

Mission    Projekte    Drittmittel    Methoden    Publikationen    Mitarbeiter/innen

Drittmittel

“Exploitation of a novel host cell-based drug screen and natural product libraries for lead compound identification with anti-mycobacterial activity“– TTU TB, Deutsches Zentrum für Infektionsforschung (DZIF), BMBF (2016-2020)

“Validation of the γ-glutamylpolyamine synthetase GlnA3Mt as a promising target for development of novel anti-tubercular drugs (GPS-TBT)“ – BMBF, Programm: Targetvalidierung für die pharmazeutische Wirkstoffentwicklung  (2018-2020)

“Clade specific virulence patterns of M. tuberculosis complex strains in human macrophages - Molecular mechanisms underlying phagosomal escape and induction of cell death”- Deutsche Forschungsgemeinschaft (DFG), Schwerpunktprogramm SPP1580 (2012-2018)

“Isolation and Characterization of M. tuberculosis-induced lipid droplets from human primary macrophages“; Leibniz Center Infection (LCI) (2018-2021)

“Discovering new therapeutic targets and drugs to combat AMR tuberculosis: proteomics characterization and drug screening of mycobacterium-infected macrophages" –  Olav Thon Foundation, Norwegen (in Kooperation with T. Flo (N),  M. Lerm (SE) und K. Prasad (IND) (2018-2022)